Rectal Adenocarcinoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Rectal Adenocarcinoma
  • +2 more
  • Birmingham, Alabama
  • +649 more
2022-04-05
Apr 5, 2022
N
Active, not recruiting
  • Locally Advanced Rectal Adenocarcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-23
Mar 23, 2022
P
Active, not recruiting
  • Rectal Adenocarcinoma
  • Portland, Oregon
    Providence Cancer Center
2022-03-22
Mar 22, 2022
E
Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +6 more
2022-03-21
Mar 21, 2022
H
Recruiting
  • Rectal Adenocarcinoma
  • Tampa, Florida
    Moffitt Cancer Center
2022-03-18
Mar 18, 2022
A
Active, not recruiting
  • Rectal Cancer
  • +2 more
    • Aalborg, Denmark
      Aalborg University Hospital
    2022-03-01
    Mar 1, 2022
    M
    Not yet recruiting
    • Rectal Adenocarcinoma
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    2022-02-25
    Feb 25, 2022
    M
    Completed
    • Rectal Adenocarcinoma
    • +4 more
    • Quality-of-Life Assessment
    • +2 more
    • Scottsdale, Arizona
    • +1 more
    2022-02-18
    Feb 18, 2022
    M
    Recruiting
    • Rectal Adenocarcinoma
    • +4 more
    • Basking Ridge, New Jersey
    • +6 more
    2022-01-28
    Jan 28, 2022
    J
    Recruiting
    • Locally Advanced Rectal Carcinoma
    • +9 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    2022-01-13
    Jan 13, 2022
    A
    Active, not recruiting
    • Colon Adenocarcinoma
    • +8 more
    • Clobetasol Propionate
    • +3 more
    • Phoenix, Arizona
    • +21 more
    2022-01-05
    Jan 5, 2022
    M
    Active, not recruiting
    • Colon Adenocarcinoma
    • +10 more
    • Anti-PD-L1/TGFbetaRII Fusion Protein M7824
    • Houston, Texas
      M D Anderson Cancer Center
    2022-01-12
    Jan 12, 2022
    H
    Completed
    • Rectal Cancer
    • Rectal Adenocarcinoma
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    2021-12-27
    Dec 27, 2021
    U
    Recruiting
    • Colorectal Adenocarcinoma
    • +6 more
    • Aurora, Colorado
    • +4 more
    2021-11-19
    Nov 19, 2021
    M
    Active, not recruiting
    • Colon Adenocarcinoma
    • +2 more
    • Biospecimen Collection
    • +3 more
    • Conroe, Texas
    • +4 more
    2021-11-30
    Nov 30, 2021
    U
    Withdrawn
    • Rectal Adenocarcinoma
    • Chemoradiation
    • +4 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    2021-11-02
    Nov 2, 2021
    U
    Terminated
    • Rectal Adenocarcinoma
    • FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}
    • Low dose fractionated radiation therapy (LDFRT)
    • Baltimore, Maryland
      Ummc Msgcc
    2021-10-06
    Oct 6, 2021
    O
    Recruiting
    • Rectal Adenocarcinoma
    • +6 more
    • 3-Dimensional Conformal Radiation Therapy
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    2021-11-01
    Nov 1, 2021
    O
    Recruiting
    • Rectal Adenocarcinoma
    • +8 more
    • Biopsy
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    2021-10-04
    Oct 4, 2021
    F
    Recruiting
    • Colonic Neoplasms
    • +4 more
    • CADe colonoscopy using GI Genius device
    • Brescia, Italy
      Fondazione Poliambulanza Istituto Ospedaliero
    2021-09-22
    Sep 22, 2021
    U
    Active, not recruiting
    • Parastomal Hernia
    • +2 more
    • Intervention group
    • Helsinki, Finland
    • +6 more
    2021-08-10
    Aug 10, 2021
    M
    Recruiting
    • Rectal Adenocarcinoma
    • Milwaukee, Wisconsin
      Froedtert & the Medical College of Wisconsin
    2021-07-14
    Jul 14, 2021
    V
    Completed
    • Mucinous Adenocarcinoma of the Rectum
    • +9 more
    • intensity-modulated radiation therapy
    • +4 more
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    2021-07-19
    Jul 19, 2021